Welcome to the website of Michael Schlander,

  • Health Economist
    at the University of Heidelberg,
    Mannheim Institute for Public Health,
    Social and Preventive Medicine (MIPH)
  • Professor of Business Administration & Management
    at the University of Applied Economic Sciences Ludwigshafen (Germany)

To find out more, please click on the links to the left.

Recent Additions to Website:

Health Economics Effectiveness Efficiency Cost-Effectiveness Incremental Cost-Effectiveness Ratio (ICER) Cost-Effectiveness Acceptability Curve (CEAC) Budgetary Impact Affordability Health Care Innovation Management Utilization Quality Management ADHD Attention Deficit Hyperactivity Disorder NICE National Institute of Clinical Excellence appraisal assessment guidelines guidance Pharmaceuticals Pharmaceutical Industry Amphetamine Methylphenidate Atomoxetine Gesundheitsökonomie Kosten Effektivität Effizienz Kosteneffektivität Kosten-Effektivität Budget Gesundheitswesen Gesundheitssystem Finanzierung Finanzierbarkeit Innovationsmanagement InnoVal InnoVal-HC Versorgungsforschung ADHS Aufmerksamkeitsstörung Hyperaktivität Medikamente Verhaltenstherapie Arzneimittel Methylphenidat Atomoxetin Pharma Pharmazeutische Industrie Morgan Plus 8 Fettpresse Albert Schweitzer Kris Kristofferson